Defined Benefit
Insurance Assets

Private Equity Shows Persistence Amid Volatile Markets

Private Equity Shows Persistence Amid Volatile Markets
2 min 30 sec

After experiencing severe declines in public equity performance, particularly in 2Q22, investors were bracing for 1Q22 private equity returns. While the public markets declined about 5% in 1Q, private equity’s fall of 1.5% was relatively muted. Private equity returns often exhibit a smoothing effect, where declines are not as sharp as those experienced in the public markets. Venture capital and growth equity experienced the sharpest drops in 1Q, given their technology focus as well as post-IPO public equity holdings. Buyouts were nearly flat for the quarter, while credit-oriented strategies saw modest gains.

Despite the pandemic, annual fundraising has been consistent from 2019-2021 within a tight range of $900-$939 billion. Fundraising for 2022 so far is behind the pace of 2021 but is expected to end at similar levels. Fundraising timelines are extending due to a large number of funds in the market and the onset of constrained LP commitment budgets due to the public markets-related “denominator effect,” which is delaying many final closes.

2Q22 Private Equity Activity in Detail

Fundraising: Based on preliminary data, final closes for private equity partnerships in 2Q22 totaled $233 billion of commitments in 486 partnerships. (Unless otherwise noted, all data in this commentary come from PitchBook.) The dollar volume was up 3% from 1Q22, but the number of funds fell 11%. For the first half, 2022 commitments are running 13% behind those of a year ago, with the number of funds down by 39%. While the figures point to a decline from 2021, the first-half results are in fact tracking to match last year’s total because the second half of 2021 weakened as public equity markets grew volatile.

2q22 private equity

Buyouts: New buyout transactions by count fell 12% from 1Q22 to 2,668, and disclosed deal value dropped 42% to $125 billion. YTD numbers also saw declines of 16% in number of investments and 7% in disclosed value. Average buyout prices remained comparable to 2021, with a similar pattern in average leverage multiples.

VC Investments: New rounds of financing in venture capital companies totaled 10,244, with $125 billion of announced value. The number of investments preliminarily fell 24% from 1Q22, and announced value fell 25%. YTD numbers held up stronger, down only 15% for rounds and 13% for disclosed value.

Exits: There were 522 private M&A exits of private equity-backed companies, with disclosed values totaling $122 billion. The preliminary private sale count fell 18% and the announced dollar volume dropped 26%. There were 42 private equity-backed IPOs in 2Q22 raising an aggregate $7 billion, down 7% by count, with issuance being unchanged from 1Q22.

Venture-backed M&A exits totaled 680 transactions with disclosed value of $23 billion. The number of sales declined 12% from 1Q22, and announced value plunged 56%. There were 67 VC-backed IPOs in 2Q22 with a combined float of $10 billion; the count was down 9% and the issuance grew 25%.

Private Equity Performance 1Q22

Returns: With the strong downturn in public equity markets, private equity outperformance has widened given private equity’s more gradual quarterly mark-to-market valuation methodology.

Posted by

Share on facebook
Share on twitter
Share on linkedin
Related Posts
Private Markets

Private Equity Sees a Big Slowdown After Frenzy of 2021

Ashley Kahn
An update on private equity performance in 4Q23 and for the year.
Private Markets

Private Equity Investors Focus on Exits as Activity Drops

Alternatives Consulting Group
The Alternatives Consulting Group provides an update on private equity performance in 3Q23.

What Investors Need to Know About the SEC’s 2023 Private Funds Rules

Alternatives Consulting Group
The Alternatives Consulting Group analyzes the new SEC rules on unregistered private funds.
Private Markets

Private Equity Headwinds Slow Liquidity

Alternatives Consulting Group
Gary Robertson provides an update on private equity activity in 2Q23, from fundraising to exits.
Private Markets

Private Equity Starts Adjusting to Tighter Conditions

Alternatives Consulting Group
The Alternatives Consulting Group analyzes private equity activity, from fundraising to exits, in 1Q23.
Private Markets

Private Equity Decelerated in 2022, with the Outlook for 2023 Very Unclear

Alternatives Consulting Group
The Alternatives Consulting Group provides an overview of private equity activity in 4Q22 and for the full year.

Emerging Managers in Private Equity: A Guide for Success

David Smith
David Smith provides a guide for emerging managers that seek to receive institutional allocations for private equity investments.
Private Markets

3Q22 Private Equity Activity Dips but Reflects Pre-Pandemic Levels

Gary Robertson
Gary Robertson analyzes private equity activity through all stages of the investment cycle in 3Q22.
Private Markets

The Fading Unicorn: How Volatility, Inflation, and Rate Hikes Impact Venture Capital

Ashley Kahn
Ashley Kahn explains the impact of rising inflation, interest rate hikes, and market volatility on venture capital portfolios.
Macro Trends

Bubbles Bursting Everywhere

Janet Becker-Wold
Janet Becker-Wold explains how recent bubbles inflated and what their popping means for institutional investors.

Callan Family Office

You are now leaving Callan LLC’s website and going to Callan Family Office’s website. Callan Family Office is not affiliated with Callan LLC.  Callan LLC has licensed the Callan® trademark to Callan Family Office for use in providing investment advisory services to ultra-high net worth clients, family foundations, and endowments. Callan Family Office and Callan LLC are independent, unaffiliated investment advisory firms separately registered with the Securities and Exchange Commission under the Investment Advisers Act of 1940.

Callan LLC is not responsible for the services and content on Callan Family Office’s website. Inclusion of this link does not constitute or imply an endorsement, sponsorship, or recommendation by Callan LLC of their website, or its contents, and Callan LLC is not responsible or liable for your use of it. When visiting their website, you are subject to Callan Family Office’s terms of use and privacy policies.